Pharma & Biotech

The latest round of Big Pharma earnings calls delivered a sweeping look at the opportunities and challenges shaping the biopharma industry heading into the second half of 2026. Quarterly earnings seasons have

Lundbeck’s chief executive Charl van Zyl says the Danish neuroscience company is firmly on track to keep “punching above its weight” as a mid-cap challenger in the sector. The company posted sales

B. Braun Medical has initiated a recall of a single lot of Excel lactated ringers injection across the United States and Canada due to particulate contamination concerns. The recall affects product shipped

Regeneron Pharmaceuticals (REGN) has launched a five-episode video podcast series designed to transform complex scientific concepts into a calming, immersive audio-visual journey. The series, titled “Science Illuminated,” debuted on August 3 on

Xspray Pharma has received yet another Complete Response Letter from the U.S. Food and Drug Administration, further delaying approval of its leukemia drug candidate Dasynoc. The setback marks the latest in a

Independent pharmacies have long served as a frontline point of health care access for millions of Americans, but mounting financial pressures are testing their ability to remain open. Michelle Britt, senior vice

Roche is investing $750 million to double the size of its existing production facility at the Genentech campus in Hillsboro, Oregon, on the western outskirts of Portland. The Swiss pharmaceutical giant’s latest

Aurinia Pharmaceuticals (AUPH) has reached a patent infringement settlement with Teva Pharmaceuticals (TEVA) over its flagship lupus drug Lupkynis (voclosporin). The deal should prevent Teva from launching a generic version of voclosporin

Customer satisfaction across the pharmacy sector is splitting sharply, with mail-order services rising while traditional retail pharmacies struggle to retain consumer confidence. The findings come from the J.D. Power 2026 U.S. Pharmacy